Global Medical Affairs Lead

About the role

The Global Medical Lead (GML), rare disease is the strategic and medical/scientific owner of all global medical affairs activities across the rare disease portfolio, leading the end-to-end global medical strategy, evidence generation plans, and lifecycle medical activities for programs spanning early development through commercialization. As the senior medical affairs leader for the rare disease franchise within Global Medical Affairs, this individual drives integrated medical strategy, ensures robust cross-functional alignment, leads scientific engagement worldwide, and guides the development and implementation of medical plans across geographies. This role acts as the central node connecting global, regional, and local medical teams, ensuring coherent execution, knowledge flow, and scientific excellence. The GML is accountable for advancing scientific understanding, supporting optimal clinical use, and improving patient outcomes across the rare disease portfolio. The ideal candidate will bring experience across multiple stages of asset development, including both early clinical development and launch/commercialization readiness, and will demonstrate the ability to build scientific strategy in complex and evolving rare disease environments.